Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.

Psychiatry research - 30 Jun 2011

Serretti Alessandro, Chiesa Alberto, Calati Raffaella, Massat Isabelle, Linotte Sylvie, Kasper Siegfried, Lecrubier Yves, Fink Martin, Antonijevic Irina, Forray Carlos, Snyder Lenore, Bollen Joseph, Zohar Joseph, De Ronchi Diana, Souery Daniel, Mendlewicz Julien

Abstract excerpt

In the present study, aimed at investigating whether a set of single nucleotide polymorphisms (SNPs) within PTGS2 gene (rs4648276, rs2066826 and rs689466) could be associated with antidepressant response, remission and treatment resistance in a sample of major depression patients, we did not find evidence supporting any of such associations.

Read the complete abstract on PubMed

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antidepressive Agents
Share to Chi-Square Distribution
Share to Cyclooxygenase 2
Share to Depressive Disorder, Major
Share to PTGS2 gene
Share to Pharmacogenetics
Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 21168919
DOI: 10.1016/j.psychres.2010.11.023

Genes

PTGS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.PMID 21168919Read ↗

Pharmacogenetic association of bi- and triallelic polymorphisms of SLC6A4 with antidepressant response in major depressive disorder.Semantic proximity Read ↗

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.Semantic proximity Read ↗

Association between genetic polymorphism and antidepressants in major depression: a network meta-analysis.Semantic proximity Read ↗

<em>5-HTR1A</em> and <em>5-HTR2A </em>genetic polymorphisms and SSRI antidepressant response in depressive Chinese patientsSemantic proximity Read ↗

SOD2 genetic polymorphism (rs4880) has no impact on 6-month response to antidepressant treatment and inflammatory biomarkers in depressed patients.Semantic proximity Read ↗

Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants.Semantic proximity Read ↗

The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.Semantic proximity Read ↗

Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression.Semantic proximity Read ↗

RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder.Semantic proximity Read ↗

P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT.Semantic proximity Read ↗

Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.Semantic proximity Read ↗

NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar DisorderSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.